Godavari Biorefineries Investor Presentation: Key Takeaways
Q1 FY27 revenue grew 4.6% to ₹557.9 Cr, but EBITDA fell to ₹2.6 Cr. Performance was pressured by high inventory costs and raw material prices despite strong chemical segment growth.
ALFA Filings
Every announcement, straight from the exchange
Every Godavari Biorefineries earnings call announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Q1 FY27 revenue grew 4.6% to ₹557.9 Cr, but EBITDA fell to ₹2.6 Cr. Performance was pressured by high inventory costs and raw material prices despite strong chemical segment growth.
Godavari Biorefineries reported Q1 FY27 total income of ₹559.9 Cr, up 4.9% YoY. Strategy focuses on bio-based chemicals and ethanol capacity expansion.
Godavari Biorefineries delivered a turnaround in FY26, reporting ₹2,000 cr total income and a positive PAT of ₹3.5 cr, driven by operational efficiencies and debt reduction.
Godavari Biorefineries reported FY26 total income of ₹2,000.2 Cr, up 6% YoY, with EBITDA margins stabilizing at 7% as the company shifts towards high-margin bio-based specialty chemicals.